Polythiazide

多噻嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePolythiazide
Drug Alias NamePolythiazidum泊利噻嗪ReneseNephrilNSC-108161 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEdemaHypertension
Global Approved IndicationsEdemaHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1961/09/26
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsEdemaHypertension

Other Information

ATC CodeC03AA05
Related LinksWikipediaDrugBankKEGG